Nav: Home

Current Cirrhosis News and Events

Current Cirrhosis News and Events, Cirrhosis News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 17 | 671 Results
How hepatitis B and delta viruses establish infection of liver cells
Princeton University researchers have developed a new, scalable cell culture system that allows for detailed investigation of how host cells respond to infection with hepatitis B (HBV) and delta virus (HDV). (2019-06-18)
Research deepens understanding of gut bacteria's connections to human health, disease
Researchers have made an important advance in understanding the roles that gut bacteria play in human health. (2019-05-30)
Translational research led by Singapore scientists uncovers new treatment for fatty liver disease
A new treatment approach that involves blocking a protein has, for the first time, shown promising results in the treatment of fatty liver disease, in a landmark translational research collaboration between Duke-NUS Medical School, National Heart Centre Singapore and biotech company Enleofen Bio. (2019-05-22)
Walking and strength training may decrease the risk of dying from liver disease
Physical activity, including walking and muscle-strengthening activities, were associated with significantly reduced risk of cirrhosis-related death, according to research presented at Digestive Disease Week® (DDW) 2019. (2019-05-19)
Diabetes patients at higher risk of deadly liver disease, finds study of 18 million people
Many patients with potentially deadly liver cirrhosis and liver cancer are being diagnosed at late advanced stages of disease, according to a study led by Queen Mary University of London and the University of Glasgow. (2019-05-19)
High rates of liver disease progression and mortality observed in patients with NAFLD/NASH
Two independent national studies have reported high rates of liver disease progression and mortality among patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH). (2019-04-10)
Autoimmune diseases of the liver may be triggered by exposure to an environmental factor
Investigators from a large population-based study conducted in northern England have suggested that exposure to a persistent, low-level environmental trigger may have played a role in the development of autoimmune diseases of the liver within that population. (2019-04-10)
New study identifies genetic variant that could help reduce need for liver transplants
A new study from the Westmead Institute for Medical Research has identified a genetic variant associated with liver fibrosis (scarring) in chronic hepatitis C patients. (2019-04-02)
Movement toward a poop test for liver cirrhosis
In a study of people with nonalcoholic fatty liver disease and their twins and other close relatives, UC San Diego researchers were able to diagnose liver cirrhosis simply by analyzing a person's stool microbes. (2019-03-29)
WHO guidelines fail to detect half of chronic hepatitis B patients in Ethiopia needing treatment
Current World Health Organization (WHO) guidelines for chronic hepatitis B (CHB) fail to detect half of the patients in need of treatment in Ethiopia, report scientists in the Journal of Hepatology, published by Elsevier. (2019-03-28)
Mayo Clinic researchers identify potential new therapy for liver diseases
Drug therapy may effectively treat a potentially life-threatening condition associated with cirrhosis and other chronic liver diseases, according to a new study by Mayo Clinic researchers. (2019-03-22)
Hepatitis B vaccination in preadolescents lowered the disease incidence rate in Catalonia
Introducing hepatitis B vaccine in preadolescents meant a decline in the disease incidence rate by 52 percent according to a study in which the University of Barcelona took part. (2019-03-13)
New hepatitis C cases down by almost 70 percent in HIV-positive men in London
New cases of hepatitis C amongst HIV-positive men in London have fallen by nearly 70 percent in recent years. (2019-03-06)
Towards a blood test for early-stage liver disease
One in four people in Western and Asian societies develop a build-up of fat in the liver as a result of an unhealthy diet. (2019-03-01)
The Lancet: Direct-acting antivirals reduce risk of premature mortality and liver cancer for people with chronic hepatitis C
The first prospective, longitudinal study investigating treatment of chronic hepatitis C with direct-acting antivirals finds that the treatment is associated with reduced risk of mortality and liver cancer, according to a study published in The Lancet. (2019-02-11)
Connective tissue on the wrong road -- when organs start to scar
The increased deposition of connective tissue is a problem in chronic diseases of many organs. (2019-02-05)
The Lancet: Major progress against hepatitis C by 2030 is possible, but will need vast improvements in screening, prevention and treatment
A comprehensive package of prevention, screening, and treatment interventions could avert 15.1 million new hepatitis C infections and 1.5 million cirrhosis and liver cancer deaths globally by 2030 -- equal to an 80 percent reduction in incidence and a 60 percent reduction in deaths compared with 2015, according to the first study to model hepatitis C interventions globally published in The Lancet. (2019-01-28)
Publication of data for SYNB1020 a potential treatment for hyperammonemia
Synlogic, Inc., (Nasdaq: SYBX) a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medicines, today announced the publication in Science Translational Medicine of clinical data from its Phase 1 clinical study in healthy volunteers and supporting preclinical data from its investigational Synthetic Biotic candidate, SYNB1020. (2019-01-16)
Liver disease could be picked up much sooner by nurse-led tests in GP surgeries
Research carried out by scientists at the University of Southampton has shown that simple tests in GP surgeries could potentially double the diagnosis rate of liver disease where patients are not displaying any symptoms. (2018-12-21)
Alcohol use may increase among Hispanic Americans as they become more 'Americanized'
Data from over 68,000 Hispanic Americans, including first-generation immigrants and native-born individuals, indicate that people in this group who are more 'Americanized' are more likely to be drinkers, consume alcohol at greater intensity, experience more negative consequences associated with alcohol use and affect women more than men. (2018-11-26)
Colder, darker climates increase alcohol consumption and liver disease
People living in colder regions with less sunlight consume more alcohol and experience more alcoholic liver disease. (2018-11-14)
Researchers identify risk factors of advanced liver disease in cystic fibrosis patients
Children's Hospital Colorado (Children's Colorado) pediatric gastroenterologist, Michael Narkewicz, MD, recently shared results of the Prospective Study of Ultrasound to Predict Hepatic Cirrhosis in Cystic Fibrosis (PUSH), which sought to determine if liver ultrasounds could identify children and adolescents with cystic fibrosis who are at greater risk of developing advanced liver disease. (2018-11-12)
Breakthrough for treatment of fibrotic diseases
A drug combination has potential to halt a process responsible for large numbers of deaths. (2018-11-05)
Potential markers identified for early detection and prevention of liver cancer
A new study offers hope of early detection for hepatocellular carcinoma -- the second leading cause of cancer-related mortality worldwide, claiming 700,000 lives each year. (2018-10-31)
Interleukin IL-22, a new target to inhibit the progression of liver disease
Naglaa Shoukry, Ph. D., and her team have made a significant breakthrough in their research aiming to limit the progression of liver disease. (2018-10-26)
Clues to the link between obesity and liver cancer-and identification of a new risk group
New research has found a previously overlooked group of obese people may be at risk of developing deadly liver cancer. (2018-10-25)
Body clock link to steroids discovered
Scientists at The Universities of Manchester and Leeds have discovered that the time of day influences the way mice respond to steroids. (2018-09-04)
Gum disease treatment may improve symptoms in cirrhosis patients
Routine oral care to treat gum disease (periodontitis) may play a role in reducing inflammation and toxins in the blood (endotoxemia) and improving cognitive function in people with liver cirrhosis. (2018-08-29)
New target could prevent progression of liver damage to cancer
Problems like obesity and alcoholism appear to chronically trigger in the liver a receptor known to amplify inflammation in response to invaders like bacteria, scientists report. (2018-08-27)
Genetic variation may increase risk of liver damage in patients with chronic hepatitis B
A new study has shown that genetic variation may increase the risk of severe liver damage in Caucasians with chronic hepatitis B infection. (2018-07-26)
Study finds high health burdens of very high risk drinking
In an Addiction Biology study, the estimated prevalence of very high risk drinking level (VHRDL, defined as drinking >100 g of ethanol per day) in 13 European Union countries was 0.74-0.85 percent, with a risk of disease or injury of 13.5 per 100 people with VHRDL per year. (2018-07-18)
TGen-led study shows DNA methylation related to liver disease among obese patients
A TGen-led team has identified how DNA methylation is associated with a condition known as non-alcoholic fatty liver disease (NAFLD), which can lead to liver cirrhosis and death, and is one of the leading indicators for liver transplants. (2018-07-18)
Alcohol-related cirrhosis deaths skyrocket in young adults
Liver disease deaths jumped by 65 percent in the United States, from 1999-2016, disproportionately affecting adults ages 25-34. (2018-07-18)
TGen-led study identifies gene expression patterns associated with fatty liver disease
In an effort towards discovering a drug target, scientists at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, for the first time have identified significant gene expression patterns associated with obesity-related NASH inflammation and fibrosis. (2018-06-22)
Researchers find a promising new approach for treating liver cirrhosis
In a study in The American Journal of Pathology, investigators report that treatment with aleglitazar, a dual peroxisome proliferator-activated receptor-alpha/gamma (PPARα/γ) agonist, reduced inflammation, vasoconstriction, angiogenesis, mucosal disruption, and tumor necrosis factor (TNF)-α overproduction in cirrhotic rats with PH. (2018-06-18)
New radiological procedure for the diagnosis of liver disease
Researchers from Charité -- Universitätsmedizin Berlin have successfully tested a new technology for use in the assessment of overweight adolescents with liver disease. (2018-06-18)
BIDMC researchers develop decision-making tool to benefit patients with HCV
BIDMC researchers led a retrospective analysis of four randomized clinical trials focused on the effects of DAA therapies in patients with HCV-associated liver failure, and developed a new means of predicting improvement in liver function in response to DAA treatment. (2018-06-18)
Video conferencing helps PCPs improve liver disease care, survival rates
Providing physicians with virtual access to specialists can be lifesaving to liver disease patients. (2018-06-12)
Insurance denials for new hepatitis C drugs remain high nationwide, study suggests
Highly effective drugs that can cure chronic hepatitis C infection in approximately 95 percent of patients first became available in the US in 2014. (2018-06-07)
Mayo Clinic researchers take a step closer to developing a DNA test for liver cancer
A group of researchers from Mayo Clinic and Exact Sciences Corporation have completed a phase II study comparing a set of DNA markers to alpha fetoprotein as a method to test for liver cancer. (2018-06-05)
Page 1 of 17 | 671 Results
   First   Previous   Next      Last   

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".